socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Wednesday, October 13, 2004

    Halozyme Raises $13.9M
    San Diego-based Halozyme Therapeutics announced that it has received $13.9M in a private placement. The company, which is listed on the OTC bulletin board, did not disclose the investors in the PIPE. The placement agent was SG Cowen & Co. The company is backed by Cimarron Biomedical, Colt Ventures, Grove Capital, and Richie Capital, among others. Halozyme is developing and commercializing recombinant human enzymes for infertility, opthalmology, and oncology.
    posted on Wednesday, October 13, 2004 (Link to more information)

    Related companies:
    Halozyme Therapeutics

    Related stories:
    > Halozyme Therapeutics Adds Director
    > Halozyme Signs Baxter
    > Halozyme Therapeutics Expands Scientific Advisory Board
    > inQ Raises $4.5M
    > Oluma Raises $9M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Friday, August 29, 2008
    Thursday, August 28, 2008
    Wednesday, August 27, 2008
    Tuesday, August 26, 2008
    Monday, August 25, 2008